Positive judgment of the European Court of Justice strengthens the position of Redcare Pharmacy and its customers.
|
EQS-News: Redcare Pharmacy N.V.
/ Key word(s): Statement
Positive judgment of the European Court of Justice strengthens the position of Redcare Pharmacy and its customers. Sevenum, the Netherlands, 27 February 2025 – Redcare Pharmacy welcomes today's judgment of the European Court of Justice that advertising measures that promote the purchase of prescription medicines in the form of direct discounts or payments of an exact amount are allowed. This confirms Redcare Pharmacy’s long-standing position since the ECJ’s judgment in 2016 (C-148/15, Deutsche Parkinson Vereinigung) that it is entitled to grant bonuses on prescription orders to the benefit of its customers. “As Europe's leading customer-centric online pharmacy, we welcome this judgment, which offers us the opportunity to further optimise our customer offerings. We will carefully review the judgment,” Olaf Heinrich, CEO of Redcare Pharmacy, comments. Link to the ECJ press release, English and German version: https://curia.europa.eu/jcms/upload/docs/application/pdf/2025-02/cp250023en.pdf
About Redcare Pharmacy. Founded in 2001, Redcare Pharmacy (formerly Shop Apotheke Europe) is now the leading online pharmacy in Europe and currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland. The company is headquartered in Sevenum, NL in the heart of Europe, with further locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven. As the one-stop pharmacy of the future, Redcare Pharmacy offers around 12.5 million active customers a wide range of more than 150,000 products at fair prices. In addition to over-the-counter medicines, nutritional supplements, beauty and personal care products, and a wide selection of health-related items in all markets, the company also offers prescription drugs to customers in Germany, Switzerland and the Netherlands. Pharmaceutical safety is always the top priority. With pharmacy at its core, providing sound pharmaceutical advice is clearly at the center of Redcare's focus. The “Care” in the name stands for a wide range of services for all stages of life and health issues: from marketplaces to unique delivery options and medication management. Redcare Pharmacy N.V. has been listed on the Frankfurt Stock Exchange (Prime Standard) since 2016. As of June 19, 2023, the company is a member of the MDAX selection index.
27.02.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2092761 |
| End of News | EQS News Service |
|
|
2092761 27.02.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.